Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy

N/ACompletedNCT01995786

Regina Elena Cancer Institute200 enrolled

Overview

The aim of the study is to evaluate clinical and economic impact of Goal Directed Fluid Therapy according to NICE haemodynamic protocol. Haemodynamic parameters were assessed using automated pulse contour analysis (Flotrac/Vigileo®). A specific dedicated software has been developed to perform clinical and expenditures data collection, both retrospective and prospective data are archived.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

DOUBLE

Enrollment

200

Conditions

Postoperative Complications

Interventions

Goal Directed Fluid Therapy FloTrac/VigileoDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients selected for major abdominal surgery Exclusion Criteria: •Patients under the age of 18, patients with hemodynamically significant aortic regurgitation and heart rhythm disorders

Locations (1)

Regina Elena CI

Rome, Italy, Italy

Outcomes

Primary Outcomes

rate of reduction of postoperative spending

Time frame: 30 day postoperative

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.